期刊文献+

不同造模方法对大鼠多囊卵巢综合征伴胰岛素抵抗模型的影响 被引量:12

Influence of Different Model-Making Methods on the Rats Models Suffering from Polycystic Ovarian Syndrome and Insulin Resistance
下载PDF
导出
摘要 目的:采用不同方法诱导SD清洁级雌性大鼠多囊卵巢综合征(PCOS)伴胰岛素抵抗(IR)动物模型,造模完成后检测大鼠血清相关激素、空腹血糖(FPG)及空腹胰岛素(FINS)并观察卵巢局部形态学改变。方法:分别采用来曲唑、脱氢表雄酮、左旋-十八甲基炔诺酮硅胶棒联合HCG诱导大鼠PCOS伴IR模型,ELISA法测定血清促黄体生成素(LH)、促卵泡生成素(FSH)、雌二醇(E2)、睾酮(T)、空腹胰岛素(FINS)水平,并用血糖仪测定FPG,HE染色后光镜下观察卵巢局部形态。结果:A组(对照组)和B组(来曲唑组)比较,B组较A组血清FSH、FINS及T浓度升高,差异有统计学意义(P<0.05);B组血清LH浓度较A组明显升高,差异有显著统计学意义(P<0.05)。D组(左旋-十八甲基炔诺酮硅胶棒联合HCG组)与C组(对照组)比较,D组血清LH、E2浓度较C组升高,差异有统计学意义(P<0.05);D组T浓度较C组明显升高,差异有统计学意义(P<0.05)。E组(脱氢表雄酮组)中途失败剔除。A、C 2组卵巢局部形态基本正常,可见发育成熟的卵泡及优势卵泡,B、D二组未见优势卵泡,均可见卵巢多囊样改变。结论:使用来曲唑或左旋-十八甲基炔诺酮硅胶棒联合HCG诱导大鼠PCOS伴IR模型,无论在影响血清激素及FPG、FINS,还是卵巢局部形态学改变方面与临床表现很接近,符合动物PCOS伴IR造模要求。 To test the relative hormones in serum, fasting plasma glucose (FPG), fast insulin(FINS) and to observe local morphological changes of the ovary of rats after establishing SD rats models with polycystic ovarian syndrome(PCOS) and insulin resistance(IR) by using different inducing methods. Methods: Letrozole, dehydroepiandrosterone, silastic capsule of levonorgestrel subdermal together with HCG were used to induce rats models with PCOS and IR. ELISA method was adopted to test the levels of LH、FSH、E2、T and FINS in serum. Glucometer was used to test FPG. Local morphological structure of ovary was observed through light microscope after HE coloration. Results: Compared with group A(the control group), the density of FSH、FINS and T increased in group B(induced by Letrozole) and the difference was of statistical significance(P〈0.05). Compared with group A, the density of LH in serum of group B increased significantly and the difference was of great statistical significance(P〈0.05). Compared with group C (the control group), the densities of LH and E2 of group D(induced by silastic capsule of levonorgestrel subdermal together with HCG) increased and the difference was of statistical significance(P〈0.05). Compared with group C, the density of T of group D increased significantly and the difference was of great statistical significance(P〈0.05). Group E (induced by dehydroepiandrosterone) failed during the experiment and was deleted. In Group A and C, the local morphological structure of the ovaries were normal and mature follicles and dominant follicle could be seen while in group B and D, no dominant follicles could be seen and polycystic ovaries could be seen. Conclusion: In terms of the influence on serum hormones, FPG and FINS or the local morphological changes of the ovary, the rats models with PCOS and IR induced by Letrozole or silastic capsule of levonorgestrel subdermal together with HCG show similar symptoms as those in the clinic. So these methods meet the requirement of making animal models with PCOS and IR.
出处 《西部中医药》 2015年第4期11-14,共4页 Western Journal of Traditional Chinese Medicine
基金 国家自然科学基金(编号81360604) 甘肃省技术研究与开发专项计划项目(编号1305TCYA029)
关键词 造模方法 大鼠PCOS伴IR模型 激素水平 卵巢形态 model making method rat model with PCOS and IR hormone level, morphological structure of the ovary
  • 相关文献

参考文献8

  • 1彭敏,郑少珍,陈燕桢.妈富隆联合罗格列酮治疗多囊卵巢综合征伴不孕的临床疗效观察[J].中国实用医刊,2012,39(12):24-26. 被引量:4
  • 2徐叔云 卞如濂 陈修.药理实验方法学[M].北京:人民卫生出版社,1985.532.
  • 3huvray P,Nativelle C,Bureau R,et al. Study of sub- strate specificity of human aromatase by site di- rected mutagenesis [J].EurJ Biochem, 2002,269 (5): 1393-1405.
  • 4Vieira CS,Pereira FV. Tibolone in postmenopausal women with systemic lupus erythematosus a pilot study[J]. Maturitas,2009,62(3):311-316.
  • 5David A,Ehrmann DLMedical progress:polycystic ovary syndrome[R].N Engl Med,2005,352(12):1223-1236.
  • 6Gompel A,Piette JC. Is there a place for postmeno- pausal hormone therapy use in women with lupus?[J]. Panminerva Med,2008,50(3):247-254.
  • 7Yan Z,Lee GY,Anderson E. Influence of dehydroepian- drosterone on the expression of insulin-like growth factor-1 during cystogenesis in polycystic rat ovaries and in cultured rat granulosa ceils [J].Biol Reprod,1997,57(6):1509-1516.
  • 8王玉荣,谈勇.滋阴补阳序贯法对多囊卵巢综合征大鼠血清性激素水平的影响[J].中国中西医结合杂志,2011,31(3):386-390. 被引量:12

二级参考文献27

  • 1张以文.多囊卵巢综合征的现代概念[J].中华妇产科杂志,2004,39(9):577-578. 被引量:35
  • 2赵军招,叶碧绿,林金菊,林文琴,池海虹,杨海燕.耐氯米芬多囊卵巢综合征患者不孕症的治疗[J].温州医学院学报,2005,35(2):124-127. 被引量:7
  • 3周海燕.罗格列酮治疗多囊卵巢综合征25例临床分析[J].中国妇幼保健,2007,22(1):33-35. 被引量:3
  • 4唐玲芳.二甲双胍与克罗米酚联合治疗多囊卵巢综合征疗效观察[J].华夏医学,2007,20(1):17-19. 被引量:5
  • 5Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogensim due to dysregulation of androgen secretion [ J ]. Endocr Rev, 1995,16 (3) :322-353.
  • 6Fiad TM, Smith TP, Cunningham SK, et al. Decline in insulin-like growth factor I levels after clomiphene citrate does not correct hyperandrogenemia in polycystic ovary syndrome [ J ]. J Clin Endocrinol Metab, 1998, 83 (7) :2394 - 2398.
  • 7Amin AF, Abd el-Aal DE, Darwish AM, et al. Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial growth factor, and insulin-like growth factor- I in women with polycystic ovary syndrome [ J].Fertil Steril, 2003,79 (4) :938 - 941.
  • 8Hogeveen KN, Cousin P, Pugeat M, et al. Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction [ J ]. J Clin Invest, 2002, 109(7) :973-981.
  • 9Ia Marca A, Morgante G, Palumbo M, et al. Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome [ J ]. Fertil Steri1,2002,78 (6) : 1234 - 1239.
  • 10Lackey BR, Gray SL, Henricks DM. The insulin-like growth factor (IGF) system actions and interactions [ J ]. 1999,10( 3-4) :201-217. and gonadotropin regulation: Cytokine Growth Factor Rev,.

共引文献74

同被引文献114

引证文献12

二级引证文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部